Related references
Note: Only part of the references are listed.Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease
Wenbin Ding et al.
TOXICOLOGY (2020)
Supplemental taurine during adolescence and early adulthood has sex-specific effects on cognition, behavior and neurotransmitter levels in C57BL/6J mice dependent on exposure window
Josephine Brown et al.
NEUROTOXICOLOGY AND TERATOLOGY (2020)
The role of NADPH oxidases in neuronal development
Aslihan Terzi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Ammon's Horn 2 (CA2) of the Hippocampus: A Long-Known Region with a New Potential Role in Neurodegeneration
Cindy Chi-Ching Pang et al.
NEUROSCIENTIST (2019)
Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model
Liyan Hou et al.
REDOX BIOLOGY (2019)
Parkinson's disease: Mechanisms, translational models and management strategies
Chand Raza et al.
LIFE SCIENCES (2019)
Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms
Md Jakaria et al.
REDOX BIOLOGY (2019)
Roles of taurine in cognitive function of physiology, pathologies and toxication
Chaoran Chen et al.
LIFE SCIENCES (2019)
17β-Estradiol Modulates SIRT1 and Halts Oxidative Stress-Mediated Cognitive Impairment in a Male Aging Mouse Model
Mehtab Khan et al.
CELLS (2019)
On the Run for Hippocampal Plasticity
C'iana Cooper et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson's disease model by inhibiting microglial M1 polarization
Liyan Hou et al.
AMINO ACIDS (2018)
Intranasally delivered small interfering RNA-mediated suppression of scavenger receptor Mac-1 attenuates microglial phenotype switching and working memory impairment following hypoxia
Sudeshna Das et al.
NEUROPHARMACOLOGY (2018)
PSD95: A synaptic protein implicated in schizophrenia or autism?
Austin A. Coley et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization
Yuning Che et al.
CELL DEATH & DISEASE (2018)
Preventive effects of taurine against D-galactose-induced cognitive dysfunction and brain damage
Dom-Gene Tu et al.
FOOD & FUNCTION (2018)
Hippocampal area CA2: an emerging modulatory gateway in the hippocampal circuit
Amrita Benoy et al.
EXPERIMENTAL BRAIN RESEARCH (2018)
Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway
Liyan Hou et al.
REDOX BIOLOGY (2018)
Caspase-3 Mediated Cell Death in the Normal Development of the Mammalian Cerebellum
Laura Lossi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: What is the evidence?
Silvia Sorce et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
A Consensus Definitive Classification of Scavenger Receptors and Their Roles in Health and Disease
Mercy R. PrabhuDas et al.
JOURNAL OF IMMUNOLOGY (2017)
NADPH oxidases in Parkinson's disease: a systematic review
Karim Belarbi et al.
MOLECULAR NEURODEGENERATION (2017)
NADPH oxidase in brain injury and neurodegenerative disorders
Merry W. Ma et al.
MOLECULAR NEURODEGENERATION (2017)
Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation
Liyan Hou et al.
TOXICOLOGY (2017)
Physical exercise induces hippocampal neurogenesis and prevents cognitive decline
Chun-Lian Ma et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator
Wei Duan et al.
MOLECULAR NEUROBIOLOGY (2016)
NADPH oxidase 2-derived reactive oxygen species in the hippocampus might contribute to microglial activation in postoperative cognitive dysfunction in aged mice
Li-Li Qiu et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?
Grazia D. Femminella et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Developmental exposure to paraquat and maneb can impair cognition, learning and memory in Sprague-Dawley rats
Bai Li et al.
MOLECULAR BIOSYSTEMS (2016)
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models
Qingshan Wang et al.
BRAIN (2015)
Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease
Helene Hall et al.
BRAIN (2014)
Substance P Exacerbates Dopaminergic Neurodegeneration through Neurokinin-1 Receptor-Independent Activation of Microglial NADPH Oxidase
Qingshan Wang et al.
JOURNAL OF NEUROSCIENCE (2014)
Value of water mazes for assessing spatial and egocentric learning and memory in rodent basic research and regulatory studies
Charles V. Vorhees et al.
NEUROTOXICOLOGY AND TERATOLOGY (2014)
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Caroline H. Williams-Gray et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Scavenger receptors in homeostasis and immunity
Johnathan Canton et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Animal models of the non-motor features of Parkinson's disease
Kimberly McDowell et al.
NEUROBIOLOGY OF DISEASE (2012)
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
Karlijn J. Doorn et al.
PROGRESS IN NEUROBIOLOGY (2012)
The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice
Darcy Litteljohn et al.
NEUROSCIENCE LETTERS (2011)
The Epidemiology of Dementia Associated with Parkinson's Disease
Dag Aarsland et al.
BRAIN PATHOLOGY (2010)
The toxic influence of paraquat on hippocampus of mice: Involvement of oxidative stress
Qing Chen et al.
NEUROTOXICOLOGY (2010)
Losartan/Hydrochlorothiazide A Review of its Use in the Treatment of Hypertension and for Stroke Risk Reduction in Patients with Hypertension and Left Ventricular Hypertrophy
Gillian M. Keating
DRUGS (2009)
Nox proteins in signal transduction
David I. Brown et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Psychopathological features in patients with Parkinson's disease and related caregivers' burden
Florindo Stella et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2009)
Classical Inhibitors of NOX NAD(P) H Oxidases Are Not Specific
Elisabetta Aldieri et al.
CURRENT DRUG METABOLISM (2008)
Potent anti-inflammatory and neuroprotective effects of TGF-β1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglial
Li Qian et al.
JOURNAL OF IMMUNOLOGY (2008)
Refining the relationship between personality and subjective well-being
Piers Steel et al.
PSYCHOLOGICAL BULLETIN (2008)
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
T Foltynie et al.
BRAIN (2004)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
